Causal analysis of the development of uterine adenomyosis in mice
OA: closed
CC0
⤵ 7 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated the causal mechanisms underlying the development of uterine adenomyosis in a mouse model, focusing on key cellular and molecular events.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (7)
- Magnetic Resonance Imaging-guided Focused Ultrasound Surgery in a Swine Adenomyosis Model 2023
- Increase in the number of integrinbeta1-immunoreactive monocyte-lineage cells in experimentally-induced adenomyosis in mice 2003
- Suppression of the development of experimentally induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor, ONO-4817, in mice 2001
- Changes in Uterine Microvessels as a Possible Pathogenic Factor in the Development of Adenomyosis Induced by Pituitary Grafting in Mice. 1999
- Increased expression of prolactin receptor mRNA in adenomyotic uterus in mice 1997
- Disturbed Cell Arrangement, Increased Cell Membrane Permeability and Apoptotic Cell Death Occur in Adenomyotic Uterine Tissues in Mice 1997
- Animal model of uterine adenomyosis: is prolactin a potent inducer of adenomyosis in mice? 1991
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK